ADMA Biologics, Inc. (ADMA)
13.59
-0.73
(-5.10%)
USD |
NASDAQ |
Mar 23, 16:00
13.55
-0.04
(-0.29%)
Pre-Market: 09:21
ADMA Biologics Total Assets (Quarterly) : 633.35M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AtriCure, Inc. | 654.18M |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Ligand Pharmaceuticals, Inc. | 1.561B |
| ANI Pharmaceuticals, Inc. | 1.440B |
| Terns Pharmaceuticals, Inc. | 301.65M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 156.03M |
| Shareholders Equity (Quarterly) | 477.32M |
| Debt to Equity Ratio | 0.1674 |
| Current Ratio | 6.708 |
| Net Debt Paydown Yield | 0.15% |